--:--:--LOCAL ·--:--UTC
    US EQUITIESLAST CLOSE
    AAPL$333.69+1.02%
    MSFT$517.53+0.92%
    GOOGL$343.50+1.56%
    AMZN$251.52+1.33%
    NVDA$233.95+1.34%
    META$728.08+0.30%
    TSLA$370.59+4.65%
    NFLX$67.06-1.16%
    BRK.B$502.65+0.43%
    AVGO$355.14+3.35%
    DIS$102.19+0.85%
    SBUX$94.71-0.18%
    MCD$231.89+0.03%
    NKE$33.87-3.64%
    COST$920.65+0.62%
    WMT$104.26+0.00%
    HD$282.85+0.14%
    KO$85.65-0.52%
    PG$144.91+0.67%
    ORCL$142.30+3.06%
    CRM$234.69-0.84%
    ADBE$237.69-1.49%
    AMD$633.91+2.95%
    INTC$119.33-0.56%
    QCOM$184.87+1.53%
    CSCO$112.20+3.16%
    IBM$222.64-1.32%
    UBER$68.11+0.34%
    ABNB$162.43+1.22%
    SHOP$151.39+1.54%
    PYPL$52.80-0.49%
    COIN$183.00-3.32%
    PLTR$188.75-0.68%
    HOOD$112.74+1.43%
    JPM$332.38-0.24%
    V$360.66+0.23%
    MA$552.26+0.41%
    BAC$53.75+0.04%
    GS$902.56+0.66%
    LLY$1142.85-0.61%
    UNH$371.90+1.83%
    JNJ$256.03-1.02%
    PFE$27.80-1.14%
    XOM$164.01+0.12%
    BA$193.56+0.67%
    BABA$105.85-1.49%
    TSM$472.78+2.96%
    US EQUITIESLAST CLOSE
    AAPL$333.69+1.02%
    MSFT$517.53+0.92%
    GOOGL$343.50+1.56%
    AMZN$251.52+1.33%
    NVDA$233.95+1.34%
    META$728.08+0.30%
    TSLA$370.59+4.65%
    NFLX$67.06-1.16%
    BRK.B$502.65+0.43%
    AVGO$355.14+3.35%
    DIS$102.19+0.85%
    SBUX$94.71-0.18%
    MCD$231.89+0.03%
    NKE$33.87-3.64%
    COST$920.65+0.62%
    WMT$104.26+0.00%
    HD$282.85+0.14%
    KO$85.65-0.52%
    PG$144.91+0.67%
    ORCL$142.30+3.06%
    CRM$234.69-0.84%
    ADBE$237.69-1.49%
    AMD$633.91+2.95%
    INTC$119.33-0.56%
    QCOM$184.87+1.53%
    CSCO$112.20+3.16%
    IBM$222.64-1.32%
    UBER$68.11+0.34%
    ABNB$162.43+1.22%
    SHOP$151.39+1.54%
    PYPL$52.80-0.49%
    COIN$183.00-3.32%
    PLTR$188.75-0.68%
    HOOD$112.74+1.43%
    JPM$332.38-0.24%
    V$360.66+0.23%
    MA$552.26+0.41%
    BAC$53.75+0.04%
    GS$902.56+0.66%
    LLY$1142.85-0.61%
    UNH$371.90+1.83%
    JNJ$256.03-1.02%
    PFE$27.80-1.14%
    XOM$164.01+0.12%
    BA$193.56+0.67%
    BABA$105.85-1.49%
    TSM$472.78+2.96%
    Plug stock market data into your AI agent — one command: Get your free API key →
    LoginGet API Key
    Company data coverage · NYSE

    MRK — Merck & Co.

    Data coverage, completeness and provenance for Merck & Co. in the Stock Market API — Health Care · Drug Manufacturers - General.

    Core-field completeness
    94.1%
    Statement periods
    FY2021–FY2025
    Filings archived
    0
    Price captured
    2026-10-03 23:12 UTC

    Profile

    Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

    Employees: 73,000 · Website: https://www.merck.com · Profile fields populated: 75%

    Data completeness by statement

    Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/MRK/financials.

    Income statement9/10 fields (90.0%)
    Balance sheet14/14 fields (100.0%)
    Cash flow6/6 fields (100.0%)
    Per-share3/4 fields (75.0%)

    Financial statement coverage (USD)

    Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

    PeriodPeriod end RevenueNet incomeTotal assetsTotal equity Fields populatedSource
    FY2025 2025-12-31 29 sec_edgar
    FY2024 2024-12-31 29 sec_edgar
    FY2023 2023-12-31 29 sec_edgar
    FY2022 2022-12-31 29 sec_edgar
    FY2021 2021-12-31 29 sec_edgar

    Get MRK data via the API

    Every number on this page is one API call away. Free API keys — no card required.

    Company profile

    Name, sector, industry, HQ, employees, market cap, source-tagged.

    GET /api/v1/companies/MRK

    Financial statements

    Multi-year statements with per-field source tags and completeness.

    GET /api/v1/companies/MRK/financials

    Computed ratios

    P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

    GET /api/v1/companies/MRK/metrics/summary

    Filings archive

    Report PDFs with LLM-ready markdown conversions where available.

    GET /api/v1/companies/MRK/filings

    News & announcements

    Dated press releases and announcements with source links.

    GET /api/v1/companies/MRK/news

    Quick start

    Create a free key, then:

    curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/MRK

    Query MRK programmatically

    Free tier — instant API key. Built for AI agents.

    Other NYSE · Health Care companies covered

    Frequently Asked Questions

    What data does the API provide for MRK?
    Company profile, financial statements, computed ratios, price data, filings and news for MRK, via REST endpoints under /api/v1/companies/MRK. Every financial field carries a source tag for provenance.
    How complete is MRK's financial data?
    The anchor reporting period (FY2025) has 94.1% of the 17 core statement fields populated. Primary source: sec_edgar.
    What reporting periods are covered for MRK?
    5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/MRK/financials.
    Where does MRK's data come from?
    Primary source for the latest statements: sec_edgar. The API records a source tag on every field and exposes them via /api/v1/companies/MRK/financials, so each value is traceable.